Monthly Archives: May 2014

GE Healthcare Symposium

28 May 2014: Krystan Dzorowicz TomslaLow Res Edit 0036Business Briefing

Dr Krystina Dzorowicz Tomsla represented Prof Ewa Goldys to present on CNBP technology at  the GE Healthcare Symposium in Albany, NY

This workshop was a forum for leaders in cell therapy research and product development to exchange ideas and address regulatory challenges facing this new emerging industry with potential market share estimated on 20 billion USD. It was organized by GE Healthcare Life Sciences division in their main Research and Development Centre in Albany.

$ 5.8M research funding awarded to A/Prof Andrei Zvyagin

A/Prof Andrew Zvyagin 26 May 2014:  Prestigous Grants Awarded to CNBP AI

A/Prof Andrei Zvyagin  has recently received the most prestigious grant award of the Ministry of Science and Education of the Russian Federation entitled “Biocompatible photoluminescent nanocomplexes for Theranostics” worth 90 mln. Russian roubles ( A$ 2.9 M , 2014-2016).  This grant establishes a new research centre “Laboratory of Optical Theranostics” at the Nizhny Novgorod State University, Russia. Andrei will lead the new Centre from Macquarie University.

The aims of the research program  are the development of approaches for effective diagnosis and treatment of pathologies, including: new-generation multifunctional theranostic agents based on photoluminescent inorganic nanomaterials; cellular and animal models for in vivo testing by the developed agents; instrumental means ensuring ultrahigh-sensitivity detection of the developed agents for optical bioimaging of cells and tissues.

In addition to this prestigious award, Andrei  subsequently attracted a second major grant from  the Russian Federation co-funded by a high-technology industry partner (45 mln. Russian roubles from the Ministry of Science and Education of the Russian Federation, matched dollar for dollar  by the industry partner, to the total of A$ 2.9 M, 2014-2016 ). The grant “Development of the nanotechnology-derived pharmaceutical solution based on the protein toxin and beta-emitter for the concomitant therapy of cancer” addresses new methods of oncotherapy, where photoluminescent nanoparticles play a key role.

Centre Director Visits City University London

City University London logo 21 May 2014: Visit with CNBP Partners

Professor Tanya Monro met with Partner researchers Prof Tong Sun, Grattan and Rahman. She delivered an invited seminar – New Directions in Photonics Down Under.

ABSTRACT: I will review recent research highlights from the Institute for Photonics and Advanced Sensing at The University of Adelaide including new optical materials developments, novel fabrication techniques and new laser and sensor architectures. The vision for the new ARC Centre of Excellence in Nanoscale Biophotonics – a $38M Centre headquarters in Adelaide with nodes in Sydney and Melbourne – will be presented.